CABOMETYX – First-line treatment for patients with advanced renal cell carcinoma (Non-PSONS), Tacoma, WA, 1/25

Posted on 05. Jan, 2018 by in non-PSONS

A FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA: CABOMETYX® is indicated for the treatment of patients with advanced renal cell carcinoma (RCC)*.

Daniel J. George, MD
Duke Cancer Center
January 25, 2018 | 6:00 pm pst

You are cordially invited to join us for a sit-down dinner and live simulcast with Dr. Daniel J. George,
taking place at 6:00 pm pst in Tacoma, Washington.

EL GAUCHO TACOMA | 2119 PACIFIC AVE | TACOMA, WASHINGTON 98402

RSVP
To reserve a seat, please contact Carey Miailovich at 206-817- 0626
or visit www.onclive.com/first-line- rcc

Click here to download flyer: Exelexis-Cabometyx-Tacoma-Invite

Comments are closed.